News

Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick infestations on dogs for a duration of ...
The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick ...
Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...
Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...
Bravecto Quantum, a long-acting injectable flea and tick treatment from Merck Animal Health, received Food and Drug Administration approval for dogs at least six months old.
BRAVECTO QUANTUM (fluralaner for extended-release injectable suspension) for Dogs: The most commonly reported adverse reactions in a US field study included lethargy, decreased appetite, vomiting ...
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the U.S. Food and Drug ...
Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon.